Informative video about DCA treatment for cancer - http://a.blip.tv/scripts/flash/stratos.swf?showplayerpath=http%3A%2F%2Fa.blip.tv%2Fscripts%2Fflash%2Fstratos.swf&feedurl=http%3A%2F%2Fthatchannel.blip.tv%2Frss%2Fflash&brandname=ThatChannel.com&brandlink=http%3A%2F%2Fwww.ThatChannel.com&enablejs=true&lightcolor=0xcccccc&backcolor=0x000000&frontcolor=0x333333&allowm4v=true&file=http%3A%2F%2Fblip.tv%2Frss%2Fflash%2F3688972 ;
|Scooped by Graham Player Ph.D.|
From time to time I see information about a common non-toxic chemical, dichloroacetate (DCA), circulating throughout the web and social media, and used in some cancer treatments. So I thought I would add some information here.
In 2007, Evangelos Michelakis, a cancer researcher at the University of Alberta discovered that DCA seems to inhibit the growth of cancerous tumors in mice. It is alleged to kill most types of cancer cells by disrupting the way they metabolize sugar, causing them to self-destruct without adversely affecting normal tissues. Subsequent human clinical trials showed that DCA treatment appeared to extend the lives of four of the five study participants.
So it would seem there could be some potential in further investigations and trials. However as DCA is an inexpensive widely used chemical it is not able to be patented. That means the Big Pharma companies will have no interest in investing in DCA research, as there would be no profit to be made for them. This is an important fact, as lack of profitability typically hinders ongoing and extended investigation.
There is a clinic in Toronto Canada that has been administering DCA to cancer patients as an “off-label” medication for some years. As of July 2013, the clinic had treated over 1300 cancer patients with DCA. Their experience seems to be quite favorable. Here is a link to the clinic where you can read more about their DCA approach, case studies, and published findings - http://medicorcancer.com/ .
There is continually emerging data becoming available on non-patentable natural medicines and substances that are of benefit to patients with cancer and other disease states.